MONTI, GIACOMO
 Distribuzione geografica
Continente #
EU - Europa 3.697
NA - Nord America 3.352
AS - Asia 3.140
SA - Sud America 476
AF - Africa 73
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 3
Totale 10.758
Nazione #
US - Stati Uniti d'America 3.214
RU - Federazione Russa 1.993
SG - Singapore 1.120
CN - Cina 912
IT - Italia 600
HK - Hong Kong 387
BR - Brasile 374
VN - Vietnam 265
SE - Svezia 236
DE - Germania 224
FR - Francia 153
GB - Regno Unito 120
BD - Bangladesh 113
CA - Canada 84
IN - India 83
FI - Finlandia 72
NL - Olanda 61
PL - Polonia 50
TR - Turchia 39
AT - Austria 35
JP - Giappone 35
MX - Messico 34
ZA - Sudafrica 34
ES - Italia 31
ID - Indonesia 28
AR - Argentina 26
IE - Irlanda 24
PK - Pakistan 21
IQ - Iraq 20
CO - Colombia 17
MY - Malesia 16
PH - Filippine 16
AU - Australia 15
UA - Ucraina 15
CZ - Repubblica Ceca 13
UZ - Uzbekistan 13
PE - Perù 12
AE - Emirati Arabi Uniti 11
LT - Lituania 11
TH - Thailandia 11
CL - Cile 10
HU - Ungheria 10
VE - Venezuela 10
BE - Belgio 9
EG - Egitto 9
PY - Paraguay 9
SA - Arabia Saudita 9
CH - Svizzera 8
EC - Ecuador 8
MA - Marocco 8
TN - Tunisia 8
IR - Iran 7
NO - Norvegia 7
JM - Giamaica 6
BO - Bolivia 5
LU - Lussemburgo 5
TW - Taiwan 5
UY - Uruguay 5
CR - Costa Rica 4
ET - Etiopia 4
GR - Grecia 4
IL - Israele 4
OM - Oman 4
DK - Danimarca 3
KR - Corea 3
KZ - Kazakistan 3
LV - Lettonia 3
AZ - Azerbaigian 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
KE - Kenya 2
KW - Kuwait 2
MD - Moldavia 2
MG - Madagascar 2
NI - Nicaragua 2
NP - Nepal 2
PT - Portogallo 2
RS - Serbia 2
BG - Bulgaria 1
BN - Brunei Darussalam 1
BS - Bahamas 1
EE - Estonia 1
GT - Guatemala 1
HN - Honduras 1
HR - Croazia 1
JO - Giordania 1
KH - Cambogia 1
LK - Sri Lanka 1
MK - Macedonia 1
ML - Mali 1
MM - Myanmar 1
MN - Mongolia 1
MV - Maldive 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PA - Panama 1
PR - Porto Rico 1
QA - Qatar 1
SN - Senegal 1
Totale 10.753
Città #
Dallas 953
Singapore 589
Ashburn 429
Hong Kong 376
Moscow 360
San Jose 282
New York 184
Beijing 169
Shanghai 169
Milan 157
Hefei 108
Ho Chi Minh City 94
Lauterbourg 91
Munich 82
Los Angeles 81
Boardman 72
Council Bluffs 63
Lawrence 62
Princeton 62
Hanoi 56
Santa Clara 50
São Paulo 48
Denver 42
Nuremberg 39
Orem 38
Warsaw 37
Helsinki 36
Brooklyn 31
Tokyo 31
London 28
Guangzhou 27
Poplar 27
Atlanta 25
Chennai 25
Dublin 24
Johannesburg 24
Rome 23
Frankfurt am Main 22
Turku 22
Seattle 21
Turin 20
Amsterdam 19
Manchester 19
Rio de Janeiro 19
Boston 18
Mexico City 18
Montreal 18
Phoenix 18
Toronto 18
Ankara 17
Stockholm 17
Jakarta 14
Vienna 14
Chicago 13
Falkenstein 13
San Francisco 13
Washington 13
Barnet 12
Belo Horizonte 12
Houston 12
Naples 12
Cesano Boscone 11
Tashkent 11
The Dalles 11
Da Nang 10
Hangzhou 10
Istanbul 10
Lappeenranta 10
Madrid 10
New Delhi 10
St Petersburg 10
Biên Hòa 9
Columbus 9
Haiphong 9
Kuala Lumpur 9
Paris 9
Zhengzhou 9
Baghdad 8
Bari 8
Calgary 8
Hải Dương 8
Pietra Ligure 8
Prague 8
Charlotte 7
Kassel 7
Lima 7
Mumbai 7
Rho 7
Tianjin 7
Bangkok 6
Brasília 6
Budapest 6
Gatchina 6
Geleen 6
Philadelphia 6
Pune 6
Querétaro 6
Raleigh 6
Shenzhen 6
Thái Bình 6
Totale 5.701
Nome #
Pirfenidone to prevent fibrosis in acute respiratory distress syndrome: The PIONEER study protocol 517
Sex-related mortality differences in young adult septic shock patients 344
A Randomized Trial of Acute Normovolemic Hemodilution in Cardiac Surgery 315
Secondary infections in patients hospitalized with COVID-19: incidence and predictive factors 206
Mortality after surgery in Europe: A 7 day cohort study 205
A radiological predictor for pneumomediastinum/pneumothorax in COVID-19 ARDS patients 181
Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 177
Mastering the Sequential Organ Failure Assessment Score: Critical Choices of Score Statistic, Timing, Imputations, and Competing Risk Handling in Major Trials—A Systematic Review 173
High Risk of Secondary Infections Following Thrombotic Complications in Patients With COVID-19 171
Fast reshaping of intensive care unit facilities in a large metropolitan hospital in Milan, Italy: facing the COVID-19 pandemic emergency 171
Continuous vs Intermittent Meropenem Administration in Critically Ill Patients With Sepsis: The MERCY Randomized Clinical Trial 165
Norepinephrine Salt Formulations and Risk of Therapeutic Error: Results of a National Survey 158
Effect of Remote Ischemic Preconditioning on Myocardial Injury in Noncardiac Surgery: the PRINCE Randomized Clinical Trial 156
Gas-exchange deficit and systemic hypoperfusion in COVID-19 and non-COVID-19 young adult patients with pneumonia 154
Characteristics, treatment, outcomes and cause of death of invasively ventilated patients with COVID-19 ARDS in Milan, Italy 153
Early noninvasive ventilation in general wards for acute respiratory failure: an international, multicentre, open-label, randomised trial 150
Candidemia in COVID-19 patients: incidence and characteristics in a prospective cohort compared to historical non-COVID-19 controls 145
Efficacy and safety of tocilizumab in severe COVID-19 patients: a single-centre retrospective cohort study 143
High dose esomeprazole as an anti-inflammatory agent in sepsis: Protocol for a randomized controlled trial 139
Residual lung damage following ARDS in COVID-19 ICU survivors 139
Intravenous amino acids for renal protection in patients receiving temporary mechanical circulatory support: a secondary subgroup analysis of the PROTECTION study 138
Chest CT-derived pulmonary artery enlargement at the admission predicts overall survival in COVID-19 patients: insight from 1461 consecutive patients in Italy 138
A Multinational Randomized Trial of Mega-Dose Esomeprazole As Anti-Inflammatory Agent in Sepsis 134
Amino acids and the kidney; friends or foes? 134
Continuous infusion versus bolus injection of furosemide in pediatric patients after cardiac surgery: A meta-analysis of randomized studies 132
Anakinra for patients with COVID-19: an updated systematic review and meta-analysis 131
Extracorporeal membrane oxygenation for prevention of barotrauma in patients with respiratory failure: A scoping review 130
Angiotensin II infusion and markers of organ function in invasively ventilated COVID-19 patients 126
Publisher Correction: Viral clearance after early corticosteroid treatment in patients with moderate or severe covid-19 (Scientific Reports, (2020), 10, 1, (21291), 10.1038/s41598-020-78039-1) 125
Continuous infusion versus intermittent administration of meropenem in critically ill patients (MERCY): A multicenter randomized double-blind trial. Rationale and design 124
Geoeconomic variations in epidemiology, ventilation management, and outcomes in invasively ventilated intensive care unit patients without acute respiratory distress syndrome: a pooled analysis of four observational studies 122
Hemodynamic Improvement in Acute Respiratory Distress Syndrome Patients After Venovenous Extracorporeal Membrane Oxygenation Implantation 121
Propofol and survival: a meta-analysis of randomized clinical trials 119
Prevalence, Characteristics, Risk Factors, and Outcomes of Invasively Ventilated COVID-19 Patients with Acute Kidney Injury and Renal Replacement Therapy 115
Could CPAP Devices Be Used to Ventilate Cardiac Arrest Patients? A Bench Study 114
Early predictors of clinical outcomes of COVID-19 outbreak in Milan, Italy 114
Predictors and outcomes of delirium in the emergency department during the first wave of the COVID-19 pandemic in Milan 111
Is SARS-CoV-2-induced disease a decisive factor influencing testosterone in males? Findings from a case-control ex post facto study 109
Coronavirus Disease 2019 in Recipient of Allogeneic Hematopoietic Stem Cell Transplantation: Life-threating Features Within the Early Post-engraftment Phase 109
Two months quality of life of COVID-19 invasively ventilated survivors; an Italian single-center study 107
High-dose anakinra in addition to standard of care including corticosteroids in patients with severe COVID-19 treated with non-invasive ventilation 104
Prolonged vs Intermittent Infusions of β-Lactam Antibiotics in Adults With Sepsis or Septic Shock 103
Continuous infusion versus bolus injection of furosemide in critically ill patients. A systematic review and meta-analysis 103
Noninvasive Ventilation of Patients with Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study 102
Predictors of Pneumothorax/Pneumomediastinum in Mechanically Ventilated COVID-19 Patients 100
Anakinra for patients with COVID-19: a meta-analysis of non-randomized cohort studies 98
Correction: Impact of renal-replacement therapy strategies on outcomes for patients with chronic kidney disease: a secondary analysis of the STARRT-AKI trial (Intensive Care Medicine, (2022), 48, 12, (1736-1750), 10.1007/s00134-022-06912-w) 96
Immunosuppressive strategies in invasively ventilated ARDS COVID-19 patients 96
Initiation of continuous renal replacement therapy versus intermittent hemodialysis in critically ill patients with severe acute kidney injury: a secondary analysis of STARRT-AKI trial 93
Continuous infusion versus intermittent administration of meropenem in critically ill patients. A multicenter randomized double-blind trial 92
Dexamethasone in COVID-19: does one drug fit all? 91
AED training with a 3D-printed model and a smartphone app 91
Alteplase in COVID-19 severe hypoxemic respiratory failure: the TRISTARDS multicenter randomized trial 89
Home ventilators for invasive ventilation of patients with COVID-19 89
Percutaneous tracheostomy in COVID-19 patients: a new apneic approach 89
Immunocompromised patients with acute respiratory distress syndrome: Secondary analysis of the LUNG SAFE database 87
Microvascular lung vessels obstructive thromboinflammatory syndrome in patients with COVID-19: Insights from lung intravascular optical coherence tomography 85
2012 pandemic flu 85
Citrate anticoagulation to reduce mortality in patients needing continuous renal replacement therapy 84
Clinical aspect of sepsis: an overview 84
Pulmonary Vascular Thrombosis in COVID-19 Pneumonia 84
Activities of a medical emergency team twenty years after its introduction 83
Early progressive mobilization in intensive care unit without adjunctive personnel 83
Percutaneous tracheostomy, a systematic review. 79
Non-invAsive VentIlation for early General wArd respiraTory failurE (NAVIGATE): A multicenter randomized controlled study. Protocol and statistical analysis plan 76
PREDICTORS AND OUTCOMES OF DELIRIUM IN THE EMERGENCY DEPARTMENT IN COVID-19 PATIENTS 75
Protective Hemodynamics: C.L.E.A.R.! 75
Human protein C concentrate in pediatric septic patients 72
The impact of non-blinding in critical care medicine trials 72
Death in hospital following ICU discharge: insights from the LUNG SAFE study 71
Single dilator vs. guide wire dilating forceps tracheostomy: a meta-analysis of randomised trials 70
Outcome of cardiac surgery in patients with low preoperative ejection fraction 68
Optimizing meropenem infusion: the importance of concentration and stability 65
Nonsurgical Strategies to Reduce Mortality in Patients Undergoing Cardiac Surgery: An Updated Consensus Process 65
Dexamethasone in COVID-19: does one drug fits all? 65
High doses proton pump inhibitors in sepsis: design of a randomized trial with in vitro experiments to search specific hallmarks in monocytes from septic patients and to characterize the mechanism of action of PPI 64
Meropenem Administration in Critically Ill Patients With Sepsis-Reply 63
Geo-economic variations in epidemiology, patterns of care, and outcomes in patients with acute respiratory distress syndrome: insights from the LUNG SAFE prospective cohort study 63
Mechanical ventilation in patients with cardiogenic pulmonary edema: a sub-analysis of the LUNG SAFE study 60
Long-term survival rate in patients with acute respiratory failure treated with noninvasive ventilation in ordinary wards 60
Non-invasive ventilation after cardiac surgery outside the Intensive Care Unit 59
Spinal analgesia in cardiac surgery: a meta-analysis of randomized controlled trials 58
Vitamin D and outcomes in adult critically ill patients. A systematic review and meta-analysis of randomized trials 58
Human protein C concentrates in adult septic patients 57
Interventions affecting mortality in critically ill and perioperative patients: A systematic review of contemporary trials 57
Decision making in the democracy-based medicine era: The consensus conference process 56
Identifying associations between diabetes and acute respiratory distress syndrome in patients with acute hypoxemic respiratory failure: an analysis of the LUNG SAFE database 56
Decreasing mortality with drotrecogin alfa in high risk septic patients A meta-analysis of randomized trials in adult patients with multiple organ failure and mortality >40% 56
Nerve Compression Injuries After Prolonged Prone Position Ventilation in Patients With SARS-CoV-2: A Case Series 56
Outcomes of Patients Presenting with Mild Acute Respiratory Distress Syndrome: Insights from the LUNG SAFE Study 55
Safety and efficacy of percutaneous tracheostomy techniques in critically ill patients: a comparative meta-analysis of randomized trials 54
Observed versus predicted hospital mortality in general wards patients assisted by a medical emergency team 53
Management of critically ill patients with coviD-19: suggestions and instructions from the coordination of intensive care units of lombardy 53
Hyperoxemia and excess oxygen use in early acute respiratory distress syndrome: Insights from the LUNG SAFE study 51
Levosimendan: new indications and evidence for reduction in perioperative mortality? 50
Towards zero perioperative mortality. 50
Monitoring non-invasive ventilation outside the intensive care unit 49
Preventing deaths related to percutaneous tracheostomy: safety is never too much! 48
Correction to: Potentially modifiable factors contributing to outcome from acute respiratory distress syndrome: the LUNG SAFE study (Intensive Care Medicine, (2016), 42, 12, (1865-1876), 10.1007/s00134-016-4571-5) 46
The authors reply 46
Totale 10.757
Categoria #
all - tutte 48.297
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 48.297


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211 0 0 0 0 0 0 0 0 0 0 0 1
2021/2022117 0 0 1 30 8 11 13 24 6 7 11 6
2022/2023410 142 88 26 5 15 46 16 36 14 2 8 12
2023/2024686 21 29 97 41 62 137 39 47 9 19 50 135
2024/20252.016 175 41 35 117 90 154 281 218 356 195 132 222
2025/20267.760 552 626 823 771 608 254 633 585 1.786 415 502 205
Totale 11.102